1492 Capital Management LLC Boosts Stake in Oscar Health, Inc. (NYSE:OSCR)

1492 Capital Management LLC raised its position in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 90.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 62,268 shares of the company's stock after acquiring an additional 29,522 shares during the quarter. 1492 Capital Management LLC's holdings in Oscar Health were worth $816,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of OSCR. Xponance Inc. boosted its stake in Oscar Health by 7.1% in the 1st quarter. Xponance Inc. now owns 15,423 shares of the company's stock worth $202,000 after buying an additional 1,029 shares during the last quarter. CWM LLC increased its holdings in Oscar Health by 50.7% during the 1st quarter. CWM LLC now owns 3,204 shares of the company's stock worth $42,000 after purchasing an additional 1,078 shares during the last quarter. Summit Investment Advisors Inc. increased its holdings in Oscar Health by 5.8% during the 4th quarter. Summit Investment Advisors Inc. now owns 20,838 shares of the company's stock worth $280,000 after purchasing an additional 1,141 shares during the last quarter. Oppenheimer & Co. Inc. increased its holdings in shares of Oscar Health by 4.6% in the 1st quarter. Oppenheimer & Co. Inc. now owns 28,362 shares of the company's stock valued at $372,000 after acquiring an additional 1,250 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC boosted its position in Oscar Health by 15.2% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 13,862 shares of the company's stock valued at $186,000 after purchasing an additional 1,834 shares during the period. 75.70% of the stock is owned by institutional investors and hedge funds.

Oscar Health Stock Up 1.7%

Shares of NYSE:OSCR traded up $0.25 during midday trading on Friday, reaching $14.45. The company had a trading volume of 27,810,569 shares, compared to its average volume of 39,649,032. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.22. The business's 50 day moving average price is $15.99 and its 200 day moving average price is $14.92. The stock has a market cap of $3.68 billion, a PE ratio of 51.59 and a beta of 1.90. Oscar Health, Inc. has a 1-year low of $11.20 and a 1-year high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. The company had revenue of $3 billion during the quarter, compared to analysts' expectations of $2.87 billion. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The business's revenue was up 42.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.62 earnings per share. Research analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have issued reports on OSCR. UBS Group reiterated a "sell" rating and set a $11.00 price target (down previously from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Wall Street Zen downgraded Oscar Health from a "buy" rating to a "hold" rating in a research note on Sunday, June 8th. Robert W. Baird reaffirmed a "neutral" rating and issued a $14.00 price target (down previously from $28.00) on shares of Oscar Health in a report on Friday. Piper Sandler cut Oscar Health from an "overweight" rating to a "neutral" rating and set a $14.00 price target for the company. in a report on Monday, July 14th. Finally, Raymond James Financial lowered Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Five equities research analysts have rated the stock with a sell rating and five have assigned a hold rating to the company. According to MarketBeat.com, Oscar Health presently has a consensus rating of "Hold" and an average price target of $12.21.

Insider Activity

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the completion of the sale, the director directly owned 64,512 shares in the company, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 24.39% of the company's stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.